# Platelet Rich Plasma Combined With Human Umbilical Cord Mesenchymal Stem Cells for Stage 3 and 4 Stress Injury

> **NCT06302582** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Liaocheng People's Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Pressure Injuries - Stage 3
- Pressure Injuries - Stage 4

## Interventions

- **BIOLOGICAL:** Platelet-rich plasma (PRP) combined with human umbilical cord mesenchymal stem cells (huMSCs)
- **OTHER:** Control group

## Key facts

- **NCT ID:** NCT06302582
- **Lead sponsor:** Liaocheng People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-02-29
- **Primary completion:** 2024-11-25
- **Final completion:** 2024-11-25
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06302582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06302582, "Platelet Rich Plasma Combined With Human Umbilical Cord Mesenchymal Stem Cells for Stage 3 and 4 Stress Injury". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06302582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*